title: Targeting the dendritic cell: the key to immunotherapy in cancer?
authors.forename: A
authors.initials: A
authors.lastname: Faith
authors.forename: C M
authors.initials: CM
authors.lastname: Hawrylowicz
mesh_terms: D019264:Adoptive Transfer / Q000379:methods*; D000951:Antigens, Neoplasm / Q000276:immunology; D003713:Dendritic Cells / Q000276:immunology*; D006801:Humans; D008213:Lymphocyte Activation; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000951:Antigens, Neoplasm
references.citation: Melanoma Res. 1999 Oct;9(5):474-81
references.pmid: 10596914
references.citation: Science. 2004 Jul 9;305(5681):200-5
references.pmid: 15247469
references.citation: J Immunol. 2000 May 1;164(9):4507-12
references.pmid: 10779751
references.citation: Int J Cancer. 2001 Jul 15;93(2):243-51
references.pmid: 11410873
references.citation: Int J Cancer. 2001 Nov15;94(4):459-73
references.pmid: 11745430
references.citation: Nat Rev Immunol. 2001 Nov;1(2):135-45
references.pmid: 11905821
references.citation: Nat Rev Immunol. 2002 Mar;2(3):185-94
references.pmid: 11913069
references.citation: J Exp Med. 2002 Aug 19;196(4):541-9
references.pmid: 12186845
references.citation: Blood. 2004 Oct 15;104(8):2235-46
references.pmid: 15231572
references.citation: Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14639-45
references.pmid: 15381769
references.citation: J Exp Med. 1994 Apr 1;179(4):1109-18
references.pmid: 8145033
references.citation: Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):8078-82
references.pmid: 7644541
references.citation: Lung Cancer. 1995 Aug;13(1):31-44
references.pmid: 8528638
references.citation: Nat Med. 1998 May;4(5 Suppl):525-31
references.pmid: 9585204
references.citation: Blood. 1999 Apr 1;93(7):2411-9
references.pmid: 10090953
references.citation: Clin Exp Immunol. 2005 Mar;139(3):468-75
references.pmid: 15730392
references.citation: J Leukoc Biol. 2003 Jan;73(1):3-29
references.pmid: 12525559
references.citation: Science. 2003 Apr 11;300(5617):337-9
references.pmid: 12690201
references.citation: Ann N Y Acad Sci. 2003 Apr;987:180-7
references.pmid: 12727638
references.citation: Nat Immunol. 2003 Oct;4(10):1009-15
references.pmid: 14502286
references.citation: Cancer Res. 2003 Oct 1;63(19):6478-87
references.pmid: 14559840
references.citation: J Immunol. 2003 Nov 15;171(10):5233-43
references.pmid: 14607924
references.citation: Nat Med. 2004 Jan;10(1):48-54
references.pmid: 14702634
references.citation: Blood. 2004 Mar 15;103(6):2162-9
references.pmid: 14630815
references.citation: Semin Cancer Biol. 2003 Dec;13(6):439-47
references.pmid: 15001163
references.citation: J Exp Med. 2004 Mar 15;199(6):815-24
references.pmid: 15024047
references.citation: Novartis Found Symp. 2004;256:241-54; discussion 254-69
references.pmid: 15027495
references.citation: J Immunol. 2004 Jul 15;173(2):1444-53
references.pmid: 15240741
references.citation: Science. 2004 Jul 9;305(5681):171
references.pmid: 15247452
references.citation: Science. 2004 Jul 9;305(5681):197-200
references.pmid: 15247468
references.citation: J Allergy Clin Immunol. 2000 Mar;105(3):421-9
references.pmid: 10719288